https://www.selleckchem.com/pr....oducts/netarsudil-ar
Distinct symptom subtypes are found in patients with OSA. The association between these subtypes and neurocognitive function is unclear. The purposes of this study were to assess whether OSA symptom subtypes are present in a cohort of Canadian patients with suspected OSA and evaluate the relationship between subtypes and neurocognitive function. Patients with suspected OSA who completed a symptom questionnaire and underwent testing for OSA were included. Symptom subtypes were identified using latent class analysis. Associati